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Purpose: Atypical antipsychotic drugs such as olanzapine and clozapine induce significant 
weight gain and obesity in schizophrenia and allied disorders. Prenatal infection is considered 
to be a severe impact to brain development which can lead to offspring developing late onset 
behavioural abnormalities. These abnormalities resemble some aspects of schizophrenia. This 
study aims to develop a rodent model mimicking patients of schizophrenia with metabolic 
syndrome after chronic treatment with olanzapine.  
Methods: Pregnant SD rats were injected with saline, PolyI:C (polyinosinic-polycytidylic 
acid, 8mg/kg), LPS (lipopolysaccharide, 100 microgram/kg) from gestation day 15 and 16. 
Each group was subdivided into a control and olanzapine group, and treated for 5 weeks from 
13 weeks of age. All rats throughout the experiment were fed lab chow ad libitum. Body 
weight and food and water intake were measured twice a week.  
Results: Prenatal PolyI:C and LPS rats gained weight quickly and developed obesity after 
olanzapine administration. The final body weight of the prenatal LPS group with olanzapine 
treatment was higher than the saline control (p=0.002) and LPS control groups (p=0.004) 
respectively. Prenatal infection with LPS in addition to olanzapine significantly increased 
peri-ovarian adipose weight (p=0.001). Analysis of hypothalamic neuropeptides relevant to 
body weight control and metabolism is currently ongoing.  
Conclusion: For the first time, the viral and bacterial prenatal infection models successfully 
replicate antipsychotic drug induced obesity and metabolic syndrome in SD rats. This model 
represents the diseased condition in humans brought on by prenatal viral or bacterial infection. 
This animal model will be used to study the mechanism of antipsychotic drug induced obesity 
and metabolic side effects, and to identify therapeutic targets for treatment. 
 
 
